Workflow
Bei Ke Cai Jing
icon
Search documents
6天4板中国卫通:公司股票存在短期大幅下跌的风险
Bei Ke Cai Jing· 2026-01-06 13:41
新京报贝壳财经讯1月6日,中国卫通(601698)公告,2026年1月6日,公司股票以涨停价收盘。公司股 票自2025年12月3日以来收盘价格累计上涨幅度为108.64%,同期申万军工行业涨幅23.92%,上证A指涨 幅5.31%,公司股票短期涨幅高于同期行业及上证指数涨幅,存在市场情绪过热及非理性炒作的情形, 公司股票击鼓传花效应十分明显,交易风险极大,存在短期大幅下跌的风险。目前股价已处于历史最高 点,公司股价已严重脱离基本面,存在股价短期大幅下跌的风险,投资者交易存在较大风险,敬请广大 投资者注意二级市场交易风险,理性决策,审慎投资。 ...
唐人神:大生行完成减持278.8万股
Bei Ke Cai Jing· 2026-01-06 13:41
新京报贝壳财经讯1月6日,唐人神(002567)公告,持股5%以上股东大生行于2025年12月10日至2026 年1月5日通过深圳证券交易所大宗交易方式累计减持公司股份278.8万股,占公司总股本的0.20%。大生 行持有公司股份比例由6.20%下降至6%,权益变动触及1%的整数倍。 ...
普利特:股票交易异常波动,无应披未披重大事项
Bei Ke Cai Jing· 2026-01-06 13:41
新京报贝壳财经讯1月6日,普利特(002324)发布公告称,公司股票交易价格在2025年12月31日、2026 年1月5日、2026年1月6日连续3个交易日收盘价格涨跌幅累计偏离20.76%,属异常波动。公司核查发 现,前期披露信息无更正补充之处,未发现媒体报道未公开重大信息,经营情况正常,无应披露未披露 重大事项,控股股东及实控人在异动期间未买卖公司股票,也不存在违反公平信息披露规定的情形。 ...
中国卫星:存在市场情绪过热、非理性炒作风险
Bei Ke Cai Jing· 2026-01-06 13:37
Group 1 - The core point of the article highlights that China Satellite's stock price has increased by 156.07% since December 3, 2025, significantly outperforming the military industry index, which rose by 23.92%, and the Shanghai A-share index, which increased by 5.31% [1] - Despite the substantial short-term stock price increase, the company's fundamentals have not undergone significant changes, indicating potential risks of market sentiment overheating and irrational speculation [1] - The article notes that the stock has exhibited a "hot potato" effect, suggesting high trading risks and the possibility of a rapid price decline in the short term [1]
首开股份:赵龙节辞任总经理职务,李捷接任
Bei Ke Cai Jing· 2026-01-06 13:37
新京报贝壳财经讯 1月6日,首开股份公告称,近日公司董事会收到总经理赵龙节书面辞职报告,因其 工作调整,于2026年1月6日辞任总经理,转任党委书记,继续担任董事等职,其未持有公司股份。同 日,公司第十届董事会第五十六次会议审议通过议案,同意聘任李捷为公司总经理,任期至第十届董事 会任期届满。李捷曾任公司常务副总经理等职,现任公司党委副书记等职。 ...
2连板爱朋医疗:公司近期经营情况正常
Bei Ke Cai Jing· 2026-01-06 13:37
新京报贝壳财经讯1月6日,爱朋医疗(300753)公告,公司股票交易价格于2026年1月5日、2026年1月6 日连续两个交易日内收盘价格涨幅偏离值累计超过30%。公司前期披露的信息不存在需要更正、补充之 处;公司未发现近期公共传媒报道了可能或已经对本公司股票交易价格产生较大影响的未公开重大信 息;公司近期经营情况正常,内外部经营环境未发生重大变化;公司、控股股东及实际控制人不存在关 于本公司的应披露而未披露的重大事项,或处于筹划阶段的重大事项;公司控股股东、实际控制人在股 票异常波动期间不存在买卖公司股票情形。 ...
南华生物:拟现金收购慧泽医药51%股权
Bei Ke Cai Jing· 2026-01-06 13:37
新京报贝壳财经讯1月6日,南华生物发布公告称,公司于2025年8月12日披露拟现金收购程泽能等合计 持有的慧泽医药51%股权,交易完成后慧泽医药将成控股子公司。根据初步测算,本次交易预计构成重 大资产重组,不构成关联交易,不涉及发行股份,也不会导致控制权变更。截至公告披露日,针对慧泽 医药的审计、评估等工作仍在进行,相关方就核心条款谈判,尚未签署正式收购协议,交易实施存在不 确定性。 ...
农发种业:定增申请获证监会同意注册批复
Bei Ke Cai Jing· 2026-01-06 13:37
Core Viewpoint - The company, Nongfa Seed Industry, has received approval from the China Securities Regulatory Commission (CSRC) for a stock issuance to specific investors, which is a significant step for its capital raising efforts [1] Group 1 - The company announced that it has received the CSRC's approval for its application to issue stocks to specific investors [1] - The approval is documented in the CSRC's notice, which is identified as document number 2966 [1] - The stock issuance must be carried out strictly according to the submitted application documents and issuance plan to the Shanghai Stock Exchange [1] Group 2 - The approval is valid for 12 months from the date of registration consent [1]
航天电子:存在市场情绪过热及非理性炒作的情形
Bei Ke Cai Jing· 2026-01-06 13:33
Core Viewpoint - The stock price of Aerospace Electronics has experienced a significant increase, with a cumulative rise of 123.23% since November 27, 2025, which is substantially higher than the 25.71% increase in the military industry and the 5.38% increase in the Shanghai Composite Index during the same period. However, the company's fundamentals have not changed significantly, indicating potential market overreaction and irrational speculation [1]. Summary by Category - **Stock Performance** - The stock price of Aerospace Electronics has deviated by a cumulative increase of 20% over three consecutive trading days (December 31, 2025, January 5, 2026, and January 6, 2026) [1]. - The cumulative increase of 123.23% since November 27, 2025, is significantly higher than the military industry’s increase of 25.71% and the Shanghai Composite Index’s increase of 5.38% [1]. - **Market Sentiment** - The short-term stock price increase is considered to be excessively high compared to the industry and index performance, suggesting a potential overreaction in market sentiment [1]. - There is an indication of irrational speculation surrounding the stock, as the company's fundamentals have not undergone any major changes [1].
信邦制药:公司涉嫌单位行贿罪 收到《起诉书》
Bei Ke Cai Jing· 2026-01-06 13:33
Core Viewpoint - The company, Xinbang Pharmaceutical, has received a prosecution notice from the People's Court of Kaiyang County, Guizhou Province, indicating that it may face criminal charges for unit bribery under Article 393 of the Criminal Law of the People's Republic of China [1] Summary by Relevant Categories Legal Issues - The prosecution notice suggests that the company is accused of violating the law regarding bribery, which could lead to significant legal consequences [1] Financial Impact - The announcement indicates that this major legal issue may have a negative impact on the company's profits [1]